申请人:Bristol-Myers Squibb Company
公开号:US05488064A1
公开(公告)日:1996-01-30
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof where A is phenyl, naphthyl or dihydro- or tetrahydronaphthyl optionally substituted on the aromatic ring by one to three substituents independently selected from halogen, cyano, trifluoromethyl, nitro, alkoxy, alkylsulfonyl, alkyl, cycloalkyl, aryl or a hydrogen bond donor; B is a bond or an oxygen atom and R.sup.1 to R.sup.4 are as defined herein. These compounds are beta 3 adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity and gastrointestinal diseases.
公式为##STR1##的化合物及其药用可接受盐,其中A是苯基、萘基或二氢萘基或四氢萘基,其芳环上可选地被一个到三个取代基独立地选自卤素、氰基、三氟甲基、硝基、烷氧基、烷基磺酰基、烷基、环烷基、芳基或氢键供体;B是键或氧原子,R1至R4如定义于此。这些化合物是β3肾上腺素能受体激动剂,因此在糖尿病、肥胖症和胃肠道疾病的治疗中非常有用。